$858 Million is the total value of First Light Asset Management, LLC's 60 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRMD | Buy | REPRO-MED SYSTEMS INC | $67,639,000 | +24.6% | 7,532,150 | +4.1% | 7.88% | -15.0% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $60,128,000 | +60.3% | 4,625,202 | +14.2% | 7.01% | +9.4% |
| IMMU | Sell | IMMUNOMEDICS INC | $59,140,000 | +117.5% | 1,668,740 | -17.3% | 6.89% | +48.4% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $53,532,000 | +45.9% | 5,112,910 | +13.9% | 6.24% | -0.4% |
| CDNA | Buy | CAREDX INC | $47,226,000 | +99.2% | 1,332,938 | +22.8% | 5.50% | +36.0% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $39,104,000 | +33.3% | 1,458,545 | -10.6% | 4.56% | -9.0% |
| MODN | Buy | MODEL N INC | $32,615,000 | +58.6% | 938,288 | +1.3% | 3.80% | +8.2% |
| INSM | Buy | INSMED INC | $28,213,000 | +72.6% | 1,024,438 | +0.5% | 3.29% | +17.8% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $27,732,000 | +50.6% | 280,350 | -2.0% | 3.23% | +2.8% |
| YMAB | New | Y-MABS THERAPEUTICS INC | $26,249,000 | – | 607,621 | +100.0% | 3.06% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $25,697,000 | +55.3% | 2,084,103 | +13.1% | 2.99% | +5.9% |
| GKOS | Buy | GLAUKOS CORPORATION | $25,012,000 | +794.9% | 651,021 | +618.8% | 2.91% | +510.9% |
| ATRC | Sell | ATRICURE INC | $24,262,000 | -3.8% | 539,762 | -28.1% | 2.83% | -34.3% |
| GMAB | New | GENMAB AS | $20,211,000 | – | 596,374 | +100.0% | 2.36% | – |
| PFNX | Buy | PFENEX INC | $19,612,000 | -5.0% | 2,348,799 | +0.4% | 2.28% | -35.1% |
| KRYS | New | KRYSTAL BIOTECH INC | $19,226,000 | – | 464,179 | +100.0% | 2.24% | – |
| NEO | Buy | NEOGENOMICS INC | $18,981,000 | +12.6% | 612,682 | +0.3% | 2.21% | -23.1% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $18,580,000 | +3120.1% | 294,316 | +2504.6% | 2.16% | +2109.2% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $18,535,000 | +21.8% | 236,958 | -30.8% | 2.16% | -16.9% |
| ZYME | Buy | ZYMEWORKS INC | $17,194,000 | +234.5% | 476,690 | +229.0% | 2.00% | +128.4% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $16,687,000 | +325.7% | 265,090 | +184.0% | 1.94% | +190.6% |
| XENT | Sell | INTERSECT ENT INC | $16,078,000 | -6.7% | 1,187,450 | -18.3% | 1.87% | -36.3% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $15,505,000 | +27.2% | 128,138 | -0.3% | 1.81% | -13.1% |
| HGEN | New | HUMANIGEN INC | $15,407,000 | – | 4,022,988 | +100.0% | 1.80% | – |
| CDXS | Sell | CODEXIS INC | $13,315,000 | -19.7% | 1,168,022 | -21.4% | 1.55% | -45.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $12,742,000 | +43.4% | 103,310 | -1.8% | 1.48% | -2.1% |
| TPTX | New | TURNING POINT THERAPEUTICS | $12,455,000 | – | 192,829 | +100.0% | 1.45% | – |
| SIBN | Sell | SI-BONE INC | $10,671,000 | +31.6% | 669,460 | -1.4% | 1.24% | -10.3% |
| ADVM | Buy | ADVERIUM BIOTECHNOLOGIES INC | $9,809,000 | +314.4% | 469,798 | +93.9% | 1.14% | +182.9% |
| QDEL | Sell | QUIDEL CORP | $8,804,000 | +68.2% | 39,348 | -26.5% | 1.03% | +14.9% |
| VAPO | Sell | VAPOTHERM INC | $7,720,000 | -55.9% | 188,349 | -79.7% | 0.90% | -69.9% |
| OPRX | New | OPTIMIZERX CORP | $7,688,000 | – | 590,000 | +100.0% | 0.90% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $7,655,000 | -17.3% | 129,832 | -33.7% | 0.89% | -43.6% |
| AMRN | Buy | AMARIN CORPORATION | $7,442,000 | +145.4% | 1,075,458 | +41.9% | 0.87% | +67.4% |
| SLP | Buy | SIMULATIONS PLUS INC | $7,417,000 | +72.2% | 123,984 | +0.6% | 0.86% | +17.6% |
| HCAT | Buy | HEALTH CATALYST INC | $7,304,000 | +2418.6% | 250,401 | +2155.9% | 0.85% | +1602.0% |
| MYOK | Sell | MYOKARDIA INC | $6,537,000 | +16.1% | 67,653 | -43.7% | 0.76% | -20.7% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $5,285,000 | +10.9% | 120,773 | +0.4% | 0.62% | -24.3% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $5,055,000 | +55.0% | 45,192 | +0.7% | 0.59% | +5.7% |
| LHCG | Buy | LHC GROUP INC | $2,522,000 | +25.0% | 14,467 | +0.5% | 0.29% | -14.5% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,284,000 | +26.8% | 16,713 | 0.0% | 0.27% | -13.4% | |
| PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $2,093,000 | +17.1% | 17,285 | 0.0% | 0.24% | -20.0% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $2,007,000 | -88.2% | 7,580 | 0.0% | 0.23% | -92.0% | |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,825,000 | +12.9% | 18,241 | 0.0% | 0.21% | -22.8% | |
| GWPH | Sell | GW PHARMACEUTICALS PLC | $626,000 | +11.8% | 5,100 | -20.3% | 0.07% | -24.0% |
| ABBV | Buy | ABBVIE | $587,000 | +87.5% | 5,981 | +45.4% | 0.07% | +28.3% |
| DYNT | Buy | DYNATRONICS CORP | $401,000 | +3.1% | 455,655 | +1.3% | 0.05% | -28.8% |
| SNY | SANOFI-SYNTHELABO | $339,000 | +16.5% | 6,650 | 0.0% | 0.04% | -20.0% | |
| MRK | MERCK & CO INC | $328,000 | +0.3% | 4,247 | 0.0% | 0.04% | -32.1% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $309,000 | +6.2% | 3,535 | 0.0% | 0.04% | -28.0% | |
| JNJ | JOHNSON AND JOHNSON | $304,000 | +7.4% | 2,161 | 0.0% | 0.04% | -27.1% | |
| BAX | BAXTER INTERNATIONAL INC | $281,000 | +6.0% | 3,258 | 0.0% | 0.03% | -26.7% | |
| PFE | PFIZER INC | $277,000 | +0.4% | 8,469 | 0.0% | 0.03% | -31.9% | |
| AMGN | AMGEN INC | $258,000 | +16.7% | 1,092 | 0.0% | 0.03% | -21.1% | |
| BIO | New | BIO RAD LABS INC | $247,000 | – | 548 | +100.0% | 0.03% | – |
| HRC | HILL-ROM HOLDINGS INC | $233,000 | +9.4% | 2,121 | 0.0% | 0.03% | -25.0% | |
| A | New | AGILENT TECHNOLOGIES INC | $225,000 | – | 2,548 | +100.0% | 0.03% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $204,000 | – | 692 | +100.0% | 0.02% | – |
| ANTM | New | ANTHEM INC COM | $209,000 | – | 795 | +100.0% | 0.02% | – |
| GRFS | GRIFOLS SA SPONSORED ADR CLASS B | $185,000 | -9.8% | 10,166 | 0.0% | 0.02% | -37.1% | |
| LABD | Exit | DIREXION DAILY S&P BIOTECH BEAR 3X SHARES | $0 | – | -15,401 | -100.0% | -0.04% | – |
| AGN | Exit | ALLERGAN PLC SHS | $0 | – | -2,157 | -100.0% | -0.06% | – |
| CNC | Exit | CENTENE CORPORATION | $0 | – | -8,917 | -100.0% | -0.09% | – |
| ITMR | Exit | ITAMAR MEDICAL LTD | $0 | – | -81,500 | -100.0% | -0.16% | – |
| LMAT | Exit | LEMAITRE VASCULAR INC | $0 | – | -48,129 | -100.0% | -0.20% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -195,160 | -100.0% | -0.52% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -92,047 | -100.0% | -0.72% | – |
| TECH | Exit | BIO TECHNE CORP | $0 | – | -25,356 | -100.0% | -0.82% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -22,828 | -100.0% | -0.93% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -223,722 | -100.0% | -0.93% | – |
| TRHC | Exit | TABULA RASA HEALTHCARE INC | $0 | – | -133,858 | -100.0% | -1.20% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -691,400 | -100.0% | -1.39% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -122,645 | -100.0% | -1.88% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -530,805 | -100.0% | -2.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.